COST NO FEE

BOSTON MEDICAL CENTER CORPORATION - 75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183

PIID: 75N94023F00001

Signed Date: Nov 26, 2025Effective Date: Sep 28, 2023End Date: Closed on Feb 28, 2026

Award $

$126K

Vendor

BOSTON MEDICAL CENTER CORPORATION

NAICS

541714

Signed Date

Nov 26, 2025

Key Details

Dollars Obligated

$126,095

Base & All Options

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

BOSTON, MA, 021182908, CD-MA-07

Description

75N94020D00004/75N94023F00001 - OVAPRENE VAGINAL DEVICE CLINICAL TRIAL - BOSTON MEDICAL CENTER - FY22 CAN 8054183

Context & Analysis

On Nov 26, 2025, Department of Health and Human Services obligated $126,095 to BOSTON MEDICAL CENTER CORPORATION for 75n94020d00004/75n94023f00001 - ovaprene vaginal device clinical trial - boston medical center - fy22 can 8054183. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a cost no fee contract. Competition extent: full and open competition with 16 offers received. Performance is located in BOSTON, MA. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541714 — related awards are listed below.